0 CHECKOUT

BioMarin Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2824702
  • June 2016
  • 108 pages
  • MarketLine
1 of 3

Summary
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes BioMarin Pharmaceutical, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BioMarin Pharmaceutical, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Key Findings
BioMarin Pharmaceutical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers READ MORE >

Note: Product cover images may vary from those shown
2 of 3

COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
Mergers and Acquisitions – Overview
Mergers and Acquisitions – Deal reports
CORPORATE VENTURING
Corporate Venturing – Overview
Corporate Venturing – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
CAPITAL RAISING
Capital Raising – Overview
Capital Raising – Deal reports

APPENDIX
About the Author Financial Deals Database
Deal Definition and Methodology
About the Author

List of Tables

BioMarin Pharmaceutical activity by deal type – volume (2012 -YTD2016)
BioMarin Pharmaceutical M&A average deal size – value ($m) (2012 -YTD2016)
BioMarin Pharmaceutical legal advisor ranking by value ($m)
BioMarin Pharmaceutical financial advisor ranking by value ($m)
Top Deals(2012 -YTD2016)
BioMarin Pharmaceutical targets and partners (2012 -YTD2016)
BioMarin Pharmaceutical M&A volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical M&A activity by geography (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing by geography (2012-YTD2016)
BioMarin Pharmaceutical partnership volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical partnership trend by key deal type (2012-YTD2016)
BioMarin Pharmaceutical capital raising volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical capital raising by deal type (2012-YTD2016)

List of Figures

BioMarin Pharmaceutical activity by deal type - volume (2012-YTD2016)
BioMarin Pharmaceutical M&A average deal size - value ($m)
BioMarin Pharmaceutical M&A volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical M&A activity by geography (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing by geography (2012-YTD2016)
BioMarin Pharmaceutical partnership volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical partnership trend by key deal type (2012-YTD2016)
BioMarin Pharmaceutical capital raising volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical capital raising by deal type (2012-YTD2016)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.